Literature DB >> 7476462

Modeling drug information for a prescription-oriented knowledge base on drugs.

C Milstein1, I de Zegher, A Venot, B Séné, P Pietri, B Dahlberg.   

Abstract

There exists little theoretical analysis how to represent knowledge on drugs required for computerized drug-prescription applications. A work package drug information modeling is described which was part of the European OPADE project. We describe the content and structure of a Drug Knowledge Base (DKB) designed to meet the requirements of decision-support systems in the domain of drug therapy, and to facilitate data transfer from various information sources. The definition of the DKB content is derived from the analysis of information requirements at the various stages of the process of the clinical usage of drugs (prescribing, administration, and follow-up). The DKB structure results from the classification of the various data items along two dimensions: (1) entities in the pharmaco-therapeutic domain for which information must be defined (the PharmacoTherapeutic Group, the Component, the ManufacturedPreparation, and the Presentation), and (2) the validity score of the pharmaco-therapeutic information (international, national, or local).

Mesh:

Substances:

Year:  1995        PMID: 7476462

Source DB:  PubMed          Journal:  Methods Inf Med        ISSN: 0026-1270            Impact factor:   2.176


  4 in total

1.  Methodology for the analysis and representation of the medical information about drugs in the Summary of Product Characteristics (SPC).

Authors:  A Venot; C Duclos
Journal:  Proc AMIA Symp       Date:  1999

2.  Building and evaluation of a structured representation of pharmacokinetics information presented in SPCs: from existing conceptual views of pharmacokinetics associated with natural language processing to object-oriented design.

Authors:  Catherine Duclos-Cartolano; Alain Venot
Journal:  J Am Med Inform Assoc       Date:  2003-01-28       Impact factor: 4.497

Review 3.  Cost-related information to be provided by computerised drug-prescription systems to promote cost-effective prescribing.

Authors:  C Milstein; A Venot
Journal:  Pharmacoeconomics       Date:  1997-08       Impact factor: 4.981

4.  Designing concept maps for a precise and objective description of pharmaceutical innovations.

Authors:  Maia Iordatii; Alain Venot; Catherine Duclos
Journal:  BMC Med Inform Decis Mak       Date:  2013-01-18       Impact factor: 2.796

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.